The goal of this study is to determine the status of proteomic technologies and products and assess their global growth potential over the five-year period from 2012 to 2017. The market is analyzed for the main proteomic platforms: mass spectrometry and biochips.
The biochip market was characterized by key biochip type (i.e., lab-on-a-chip, planar array, bead array) and by end-use industry (e.g., research, drug discovery and development, diagnostics, applied).
The mass spectrometry (MS) market was characterized by MS instrument type and end-use industry, as well as by MS workflow (e.g., sample preparation, chromatography, tagging and labeling reagents, and informatics).
A particular focus of the study is placed on the market for proteomic-based diagnostics products, which highlights a major future market segment for proteomic technologies. The key objective is to present a comprehensive discussion of the main commercial proteomic technologies, along with the current and future commercial potential for each of the key market segments.
The scope of the report “Proteomics: Technologies and Global Markets” covers MS instruments, consumables, workflow products, planar arrays, bead arrays and LOAC. It also covers the research, drug discovery and development, diagnostics and applied end-user market segments. The main geographical markets—North America, Europe, Japan and Rest of World (ROW)—are included.
The MS market is covered by instrument type, MS consumables, product type and end-user markets. The biochip market is covered by biochip type and the-end user market for each type. The diagnostics market is covered in some detail, including by major platform (i.e., MS, biochips), by disease type and for cancer by indication.
This report provides the current market sizes for these segments, as well as their forecasted growth through 2017.
Technology status and market driving forces are discussed. Factors that influence each market are also discussed, including growth-driving forces, industry alliances and acquisitions, applications in diagnostics and drug discovery, customer needs and competitive trends.
Key industry acquisitions and strategic alliances are given for the three-year period from 2010 through 2012.
This report (http://www.reportsnreports.com/reports/247340-proteomics-technologies-and-global-markets.html) also examines the main patent trends within the industry and profiles 83 companies, some of which are listed below:
Ablynx Nv
Activiomics Ltd.
Activx Biosciences Inc.
Adnexus Therapeutics
Advanced Proteome Therapeutics Inc.
Agilent Technologies Inc.
Applied Proteomics
Ayoxxa Biosystems Gmbh
Biodesix
Biognosys Ag
Bioproximity Llc
Bio-Rad Laboratories Inc.
Biosystems International Sas
Bruker Corporation
Calibrant Biosystems Inc.
Cambridge Protein Arrays Ltd.
Caprion Proteomics
Caprotec Bioanalytics Gmbh
Crelux Gmbh
Crystalgenomics Inc.
Danaher Corp.
Diassess
Digilab Inc.
Dnano Systems Llc
Durin Technologies Inc.
Dvs Sciences Inc.
Evotec Ag
General Electric Co.
Glaxosmithkline Plc
Gl Sciences Inc.
Gwc Technologies
Immunovia Ab
Imtakt Corporation
Integrated Diagnostics
Iris International Inc.
Leap Technologies Inc.
Life Technologies Inc.
Luminex Corporation
Merck Kgaa
Microlytic Aps
Mrm Proteomics Inc.
Mosaiques Diagnostics and Therapeutics Ag
Myriad Genetics Inc.
Nextgen Sciences Inc.
Olink Bioscience
Oncoplex Dx
Opko Health Inc.
Perkin Elmer Inc.
Pfizer Inc.
Phenomenex
Phylogica Ltd.
Pressure Biosciences Inc.
Pronota Nv
Protea Biosciences Inc.
Proteome Sciences
Proteomics International Pty Ltd
Provista Diagnostics Inc.
Qiagen Nv
Quanterix Inc.
Quest Diagnostics Inc.
Repligen Corporation
Samdi Tech Inc.
Shimadzu Corporation
Shiseido Company Ltd.
Showa Denko Kk
Sigma Aldrich
Singulex Inc.
Siscapa Assay Technologies
Somalogic Inc.
Sphere Fluidics Ltd.
Spoton Clinical Diagnostics Ltd.
Synageva Biopharma
Talking20 Inc.
Theranostics Health
Thermo Fisher Scientific Inc.
Thorne Diagnostics Inc.
Tosoh Corporation
Universal Biosensors Ltd.
Vermillion Inc.
Viral Genetics Inc.
Waters Corp.
Xencor Inc.
Ymc Co. Ltd.
Contact [email protected] for further information.